A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates

Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation

Anti Human CD163 Antibody, clone EDHu-1

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). - Abstract - Europe PMC

Inflammatory environment induced in 3D liver NASH model (A) Time course

Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis - ScienceDirect

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists

Human‐based systems: Mechanistic NASH modelling just around the corner?

2023-5892

A guide to the organ-on-a-chip Nature Reviews Methods Primers

Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis - ScienceDirect

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). - Abstract - Europe PMC

Marked reduction in hepatic steatosis following combined treatment with